[1]Taimr P, Higuchi H, Kocova E, et al.Activated stellate cellsexpress the TRAIL receptor-2/death receptor-5 and un-dergo TRAIL mediated apoptosis[J].Hepatology, 2003, 37 (1) :87-95.
|
[2]高杰, 赵勇华, 康鹏, 等.TRAIL诱导大鼠肝星状细胞系HSC-T6凋亡及机制研究[J].临床肝胆病杂志, 2010, 26 (3) :300-303.
|
[3]Edderkaoui M, Hong P, Lee JK, et al.Insulin-like growthfactor-I receptor mediates the prosurvival effect of fibronec-tin[J].J Biol Chem, 2007, 282 (37) :26646-26655.
|
[4]Kao CL, Lin HT, Chen YW, et al.Fibronectin suppresses li-popolysaccharide-induced liver damage and promotes thecytoprotection abilities of hepatocyte-like cells derived fromhuman bone marrow mesenchymal stem cells[J].Trans-plant Proc, 2007, 39 (10) :3444-3445.
|
[5]Saile B, Knittel T, Matthes N, et al.CD95/CD95L-media-ted apoptosis of the hepatic stellate cell.A mechanism termi-nating uncontrolled hepatic stellate cell proliferation during he-patic tissue repair[J].Am J Pathol, 1997, 151 (5) :1265-1272.
|
[6]Madsen CD, Sidenius N.The interaction between urokinasereceptor and vitronectin in cell adhesion and signalling[J].Eur J Cell Biol, 2008, 87 (8-9) :617-629.
|
[7]Almeida EA, Ili c'D, Han Q, et al.Matrix survival signalling:from fibronectin via focal adhesion kinase to c-jun NH2-terminal kinase[J].J Cell Biol, 2000, 149 (3) :741-754.
|
[8]白莉, 曹传平, 张映辉, 等.促凋亡蛋白Bid诱导肝细胞凋亡的机制[J].中国生物化学与分子生物学报, 2004, 20 (5) ;670-674.
|
[1] | Zhiyi WANG, Guangyue YANG, Wei ZHANG, Yaqiong PU, Xin ZHAO, Wenting MA, Xuling LIU, Liu WU, Le TAO, Cheng LIU. Role of podoplanin in hepatic stellate cell activation and liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 533-538. doi: 10.12449/JCH240316 |
[2] | Lingling ZHU, Yani ZHANG, Tingting SHI, Yang WU, Chun GAO, Xiaohui YU, Yujing HE, Jiucong ZHANG. The role of tumor necrosis factor-α in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(11): 2320-2325. doi: 10.12449/JCH241129 |
[3] | Wentao XIE, Kangkang YU, Qi CHENG, Ning LI. Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B[J]. Journal of Clinical Hepatology, 2023, 39(12): 2845-2850. doi: 10.3969/j.issn.1001-5256.2023.12.015 |
[4] | Zhen TIAN, Lisha WANG, Naijuan YAO, Yingren ZHAO, Litao RUAN. Role and mechanism of hepatic stellate cells in the pathogenesis of mice with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(3): 642-647. doi: 10.3969/j.issn.1001-5256.2021.03.027 |
[5] | Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029 |
[6] | Ding Qian, Li Zhen, Liu Bin, Ling LiPing, Zhang ChunQing. Inhibitory effect of carvedilol on human hepatic stellate cell activation and fibrosis induced by platelet-derived growth factor-BB and related mechanisms of action[J]. Journal of Clinical Hepatology, 2017, 33(3): 485-491. doi: 10.3969/j.issn.1001-5256.2017.03.018 |
[7] | Zhao WeiHua, Wang YanHong, Cong Min. Regulatory effect of transforming growth factor-β on activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2195-2198. doi: 10.3969/j.issn.1001-5256.2016.11.044 |
[8] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[9] | Chi ZhaoChun, Geng ZhangXin. Application of tumor necrosis factor antagonists in hepatic disease treatment[J]. Journal of Clinical Hepatology, 2015, 31(7): 1176-1179. doi: 10.3969/j.issn.1001-5256.2015.07.045 |
[10] | Weng ShanGeng, Xu ChangGuo, Sun Ying, Shi Zheng, Lin LiJuan. Study on the apoptosis of rat hepatic stellate cells induced by kapamycin[J]. Journal of Clinical Hepatology, 2012, 28(3): 219-222. |
[11] | Zhang LiLi, Guo XiaoHong, Liu LiXin, Zhang QianQian. IGFBPrP1 siRNA induced apoptosis in rat hepatic stellate cells and its mechanism[J]. Journal of Clinical Hepatology, 2011, 27(9): 965-969+979. |
[12] | Gao Jie, Zhao YongHua, Kang Peng, Liang Ming, Li ShuChen. Molecular mechanism of apoptosis in rat hepatic stellate cells HSC-T6 induced by TRAIL[J]. Journal of Clinical Hepatology, 2010, 26(3): 300-303. |
[13] | Shao Dong, Chen Ming, Wei Lai, Feng Xia, Liu ChengYuan. The realationship among activation-induced cell apoptosis of peripheral blood lymphocytes with the level of HBVDNA in the serum and Th1/Th2-type cytokins production in chronic hepatitis B virus infection patients[J]. Journal of Clinical Hepatology, 2004, 20(6): 339-340. |
[14] | Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140. |
[16] | Zhu YingHua, Song HongLi, Zhang Yi, Yu Guang, Han JiJin. The Clinieal study about interleukin-1 and tumor necrosis factor Alpha in hepatocirrhosis[J]. Journal of Clinical Hepatology, 2001, 17(4): 233-234. |
[17] | Wang JunXue, Wang GuoJun, Cai Xiong. The effects of oxymatrine on apoptosis induced by TNF-α in human liver cell line L02[J]. Journal of Clinical Hepatology, 2001, 17(4): 210-211+217. |